Brenda Cooper, MD
- Bone Marrow Transplantation
- Malignant Hematology
Patient Satisfaction Reviews
4.8 out of 5
Patient Comments (3)
Reviewed On 12/28/2018
Dr. Brenda Cooper is a superb Oncologist. I would recommend you would send out survey on Seidman 1st floor infusion center. As I have commented before R.N. Nurse, **** is a spectacular individual whom is stupendous, kind, just an incredible person with exceptional class a true professional. *****is the best I have ever encountered a wonderful Beautiful individual. Thank You *****
Reviewed On 12/26/2018
dr. Cooper and her staff are the best ever.*****
Reviewed On 12/17/2018
Dr Cooper gave me back my life *****Her team, the nurses and staff on the 3rd floor were surprtb! All of the staff are super caring and professional. I've had confidence in them which in turn helped me recover. Life is Sweet, thanks to the Siedman Cancer Center Staff and Dr Cooper.
- Medical Oncology - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Fellowship | Medical Oncology
Medical Oncology - University Hospitals Of Cleveland (1990 - 1990)
Fellowship | Medical Oncology
Medical Oncology - University Of Maryland Medical Center (1987 - 1989)
Residency | Internal Medicine
Internal Medicine - Francis Scott Key Medical Center (1985 - 1987)
Internship | Internal Medicine
Internal Medicine - Francis Scott Key Medical Center (1984 - 1985)
Johns Hopkins University School Of Medicine (1984)
Cornell University (1980)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Brenda Cooper did not disclose any Outside Relationships with Industry.